We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Franklin Covey Co | NYSE:FC | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 37.67 | 1 | 09:09:44 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
(Exact name of registrant as specified in its charter)
Commission File No.
|
|
|
| ||
(State or other jurisdiction of incorporation) |
| (IRS Employer Identification Number) |
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (
Former name or former address, if changed since last report: Not Applicable
______________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □
As noted below, on January 24, 2025, the shareholders of Franklin Covey Co. (the Company) approved Amendment No. 1 (the Amendment) to the Franklin Covey Co. 2022 Omnibus Incentive Plan (the 2022 Plan). The 2022 Plan was adopted by the Company’s Board of Directors on November 12, 2021, and the Amendment was adopted by the Company’s Board of Directors on November 15, 2024. With shareholder approval obtained, the 2022 Plan is amended to increase the number of shares available by 575,000 shares. Subject to adjustment in certain circumstances, the 2022 Plan now authorizes up to 1,575,000 shares of common stock for issuance.
Any employees, officers, consultants, advisors, independent contractors, or non-employee directors of the Company or any of its subsidiaries or affiliates are eligible to receive an award under the 2022 Plan. Generally, grants may be made in any of the following forms:
Stock Options
Stock Appreciation Rights
Restricted Stock and Restricted Stock Units
Other Stock-Based Awards
A more complete summary of the 2022 Plan appears on pages 50 to 59 of the Company’s Proxy Statement as filed with the Securities and Exchange Commission on December 20, 2024, as revised by Amendment No. 1 and Amendment No. 2 to the Proxy Statement filed on January 13, 2025, and is incorporated by reference herein. The foregoing description and the summary contained in the Company’s Proxy Statement, as amended, do not purport to be complete and are qualified in their entirety by reference to the full text of the 2022 Plan and the Amendment, which are attached as Exhibits 10.1 and 10.2, respectively, to this current report on Form 8-K and incorporated by refence herein.
The Company held its Annual Meeting of Shareholders on Friday, January 24, 2025. For more information on the following proposals, refer to the Company’s Proxy Statement filed with the Securities and Exchange Commission on December 20, 2024, the relevant portions of which are incorporated herein by reference. The matters voted on and the results of the votes are as follows:
1.The following nominees for Director were elected. Each person elected will serve until the next annual meeting of shareholders or until such person’s successor is elected and qualified.
|
|
|
|
|
|
|
Nominee |
| Number of Votes Cast For |
| Number of Votes Withheld |
| Broker Non-Votes |
Anne H. Chow |
| 8,470,986 |
| 1,164,047 |
| 1,671,059 |
Craig Cuffie |
| 9,449,913 |
| 185,120 |
| 1,671,059 |
Donald J. McNamara |
| 9,382,793 |
| 252,240 |
| 1,671,059 |
Joel C. Peterson |
| 9,415,412 |
| 219,621 |
| 1,671,059 |
Nancy Phillips |
| 8,949,289 |
| 685,744 |
| 1,671,059 |
Efrain Rivera |
| 9,439,418 |
| 195,615 |
| 1,671,059 |
Derek C.M. van Bever |
| 8,853,212 |
| 781,821 |
| 1,671,059 |
Paul S. Walker |
| 9,444,477 |
| 190,556 |
| 1,671,059 |
Robert A. Whitman |
| 8,977,404 |
| 657,629 |
| 1,671,059 |
2.The advisory vote for the approval of executive compensation as described and presented in the Compensation Discussion and Analysis of the Company’s Proxy Statement was approved with 9,093,586 votes in favor; 511,411 votes against; and 30,036 abstentions. The number of broker non-votes was 1,671,059.
3.The ratification of the appointment of Deloitte & Touche, LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending August 31, 2025 was approved with 11,188,529 votes cast in favor; 95,220 votes against; and 22,343 abstentions. There were no broker non-votes for this proposal.
4.Amendment No. 1 to the Franklin Covey Co. 2022 Omnibus Incentive Plan was approved with 9,255,222 votes cast in favor; 350,571 votes against; and 29,240 abstentions. The number of broker non-votes was 1,671,059.
Item 9.01 Financial Statements and Exhibits
(d)Exhibits
10.2Amendment No. 1 to the Franklin Covey Co. 2022 Omnibus Incentive Plan.
104Cover Page Interactive Data File – the cover page XBRL tags are embedded within the inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
| FRANKLIN COVEY CO. | |
|
|
|
|
Date: January 24, 2025 |
| By: | /s/ Stephen D. Young |
|
|
| Stephen D. Young |
|
|
| Chief Financial Officer |
Exhibit 10.2
AMENDMENT NO. 1 TO FRANKLIN COVEY CO. 2022 OMNIBUS INCENTIVE PLAN
WHEREAS, Franklin Covey Co. (the “Company”) sponsors and maintains the Company’s 2022 Omnibus Incentive Plan (the “2022 Plan”); and
WHEREAS, the Company proposes to amend the 2022 Plan to increase the number of the Company’s common shares reserved for issuance thereunder, subject to the approval of the Company’s stockholders at the Company’s 2025 annual meeting of shareholders (the “Annual Meeting”) and effective as of the date of such approval (the “Effective Date”).
Subject to the approval of the Company’s shareholders at the Annual Meeting (the “Shareholder Approval”), the 2022 Plan is hereby amended as of the Effective Date as follows:
Amendment to 2022 Plan.
Section 4(a)(i) of the 2022 Plan is hereby amended and restated to read in its entirety as follows:
“(i) 1,575,000 Shares, plus”
Section 6(a)(iv)(A) of the 2022 Plan is hereby amended and restated to read in its entirety as follows:
“(A) The aggregate number of Shares that may be issued under all Incentive Stock Options under the Plan shall be 1,575,000 Shares.”
Failure to Obtain Shareholder Approval. If the Shareholder Approval is not obtained, then this Amendment No. 1 to the 2022 Plan shall become null and void and shall immediately terminate.
Effect of this Amendment. Except as expressly amended hereby, the 2022 Plan shall continue in full force and effect in accordance with the provisions thereof.
IN WITNESS WHEREOF, the Company, by its duly authorized officer, has executed this Amendment No. 1 to the Franklin Covey Co. 2022 Omnibus Incentive Plan on the date indicated below.
FRANKLIN COVEY CO.
Date: [____], 2024 |
By: |
|
|
Name |
|
|
Office |
|
Document And Entity Information |
Jan. 24, 2025 |
---|---|
Document And Entity Information [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 24, 2025 |
Entity Registrant Name | FRANKLIN COVEY CO. |
Entity File Number | 001-11107 |
Entity Incorporation, State or Country Code | UT |
Entity Tax Identification Number | 87-0401551 |
Entity Address, Address Line One | 2200 West Parkway Boulevard |
Entity Address, City or Town | Salt Lake City |
Entity Address, State or Province | UT |
Entity Address, Postal Zip Code | 84119-2099 |
City Area Code | 801 |
Local Phone Number | 817-1776 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $.05 Par Value |
Trading Symbol | FC |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0000886206 |
1 Year Franklin Covey Chart |
1 Month Franklin Covey Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions